1. Home
  2. HUMA vs ACTG Comparison

HUMA vs ACTG Comparison

Compare HUMA & ACTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMA
  • ACTG
  • Stock Information
  • Founded
  • HUMA 2004
  • ACTG 1993
  • Country
  • HUMA United States
  • ACTG United States
  • Employees
  • HUMA N/A
  • ACTG N/A
  • Industry
  • HUMA Biotechnology: Pharmaceutical Preparations
  • ACTG Multi-Sector Companies
  • Sector
  • HUMA Health Care
  • ACTG Miscellaneous
  • Exchange
  • HUMA Nasdaq
  • ACTG Nasdaq
  • Market Cap
  • HUMA 503.1M
  • ACTG 414.8M
  • IPO Year
  • HUMA N/A
  • ACTG 1996
  • Fundamental
  • Price
  • HUMA $3.54
  • ACTG $4.21
  • Analyst Decision
  • HUMA Strong Buy
  • ACTG Strong Buy
  • Analyst Count
  • HUMA 7
  • ACTG 1
  • Target Price
  • HUMA $13.43
  • ACTG $7.00
  • AVG Volume (30 Days)
  • HUMA 1.5M
  • ACTG 114.0K
  • Earning Date
  • HUMA 03-21-2025
  • ACTG 03-13-2025
  • Dividend Yield
  • HUMA N/A
  • ACTG N/A
  • EPS Growth
  • HUMA N/A
  • ACTG N/A
  • EPS
  • HUMA N/A
  • ACTG 0.39
  • Revenue
  • HUMA N/A
  • ACTG $165,779,000.00
  • Revenue This Year
  • HUMA N/A
  • ACTG N/A
  • Revenue Next Year
  • HUMA $4,344.68
  • ACTG $84.79
  • P/E Ratio
  • HUMA N/A
  • ACTG $11.03
  • Revenue Growth
  • HUMA N/A
  • ACTG 261.08
  • 52 Week Low
  • HUMA $2.81
  • ACTG $3.92
  • 52 Week High
  • HUMA $9.97
  • ACTG $5.74
  • Technical
  • Relative Strength Index (RSI)
  • HUMA 29.77
  • ACTG 40.48
  • Support Level
  • HUMA $3.70
  • ACTG $4.30
  • Resistance Level
  • HUMA $4.14
  • ACTG $4.38
  • Average True Range (ATR)
  • HUMA 0.22
  • ACTG 0.11
  • MACD
  • HUMA -0.06
  • ACTG 0.00
  • Stochastic Oscillator
  • HUMA 0.00
  • ACTG 13.04

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.

About ACTG Acacia Research Corporation (Acacia Tech)

Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, significant capital base, and deep industry relationships to drive value. Acacia evaluates opportunities based on the attractiveness of the underlying cash flows, without regard to a specific investment horizon. Acacia operates its businesses based on three key principles of people, process, and performance and has built a management team with demonstrated expertise in research, transactions and execution, and operations and management.

Share on Social Networks: